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ORIGINAL RESEARCH
Left Atrial Reservoir Strain by Speckle 
Tracking Echocardiography: Association 
With Exercise Capacity in Chronic Kidney 
Disease
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BACKGROUND: Left atrial (LA) function plays a pivotal role in modulating left ventricular performance. The aim of our study was 
to evaluate the relationship between resting LA function by strain analysis and exercise capacity in patients with chronic kidney 
disease (CKD) and evaluate its utility compared with exercise E/e’.
METHODS AND RESULTS: Consecutive patients with stage 3 and 4 CKD without prior cardiac history were prospectively re-
cruited from outpatient nephrology clinics and underwent clinical evaluation and resting and exercise stress echocardiogra-
phy. Resting echocardiographic parameters including E/e’ and phasic LA strain (LA reservoir [LASr], conduit, and contractile 
strain) were measured and compared with exercise E/e’. A total of 218 (63.9±11.7 years, 64% men) patients with CKD were 
recruited. Independent clinical parameters associated with exercise capacity were age, estimated glomerular filtration rate, 
body mass index, and sex (P<0.01 for all), while independent resting echocardiographic parameters included E/e’, LASr, and 
LA contractile strain (P<0.01 for all). Among resting echocardiographic parameters, LASr demonstrated the strongest positive 
correlation to metabolic equivalents achieved (r=0.70; P<0.01). Receiver operating characteristic curves demonstrated that 
LASr (area under the curve, 0.83) had similar diagnostic performance as exercise E/e’ (area under the curve, 0.79; P=0.20 on 
DeLong test). A model combining LASr and clinical metrics showed robust association with metabolic equivalents achieved 
in patients with CKD.
CONCLUSIONS: LASr, a marker of decreased LA compliance is an independent correlate of exercise capacity in patients with 
stage 3 and 4 CKD, with similar diagnostic value to exercise E/e’. Thus, LASr may serve as a resting biomarker of functional 
capacity in this population.
Key Words: chronic kidney disease ■ diastolic dysfunction ■ exercise capacity ■ exercise echocardiography ■ left atrial strain  
■ left atrium
Exercise capacity is an established prognostic de-terminant of adverse cardiovascular outcomes and mortality, providing incremental value over es-
tablished cardiovascular risk factors.1,2 In patients with 
chronic kidney disease (CKD), reduced exercise capac-
ity is common and similarly correlates with high cardio-
vascular risk.3,4 The cause of reduced exercise capacity 
in CKD is multifactorial, in part related to the increasingly 
sedentary lifestyle and frailty that accompanies progres-
sion of renal disease.4 Additionally, diastolic dysfunction, 
driven by left ventricular (LV) hypertrophy, increased vas-
cular stiffness and systemic hypertension, is considered 
to be another contributory factor for poor cardiorespira-
tory capacity in these patients.5
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The ratio of the transmitral E velocity to tissue 
Doppler mitral annular e’ velocity following exercise 
(exercise E/e’), has recently been shown to refine 
diagnosis of diastolic dysfunction and predict poor 
exercise capacity in patients with CKD.6 However, 
stress testing to evaluate exercise E/e’ can be tech-
nically challenging, particularly in patients with CKD 
with high frailty levels and exercise-limiting comorbid 
disease.7 Therefore, a marker of cardiorespiratory fit-
ness that can be obtained at rest is easier and more 
practical and would aid risk stratification in these 
patients.
The left atrium has an important role in modu-
lating LV performance, contributing up to a third of 
cardiac output.8 Given its dynamic relationship with 
the LV chamber, left atrial (LA) function has been 
considered to predominantly reflect changes in LV 
systolic and diastolic function. More recently, there 
is evidence that LA dysfunction in patients with CKD 
is independently modulated by renal function,9 that 
may be indicative of a CKD-associated atrial myop-
athy. Additionally, in disease states associated with 
systemic inflammation such as CKD, alterations in LA 
function independent of diastolic dysfunction have 
been described.10
Though a variety of parameters have been defined, 
there is no single parameter that best defines LA func-
tion. Conventionally, LA function is assessed by volu-
metric measures. Recently, however, evaluation of LA 
phasic function by strain analysis has been shown to be 
feasible and reproducible, with alterations in LA strain 
occurring before changes in LA volumes.11,12 Based on 
these considerations, the objective of our study was to 
evaluate the relationship between LA function by strain 
analysis and exercise capacity in patients with CKD 
that may provide additional insights into exercise phys-
iology beyond diastolic function. Further, we sought to 
compare the utility of resting echocardiographic pa-
rameters to exercise E/e’ with regard to its association 
with reduced exercise capacity.
METHODS
The data that support the findings of the present study 
are available from the corresponding authors on rea-
sonable request.
Study Population
Patients with stage 3 (estimated glomerular filtration rate 
[eGFR], 30–60 mL/min per 1.73 m2) and stage 4 (eGFR, 
15–29  mL/min per 1.73  m2) CKD by the Modification 
of Diet in Renal Disease formula were prospectively re-
cruited from outpatient nephrology clinics across 2 ter-
tiary hospitals in New South Wales, Sydney, Australia, 
from January 2011 to December 2017.
Recruited patients were ≥18  years of age without 
prior cardiac history and had “stable” renal function, 
defined as <5% change in baseline eGFR for 3 months 
before enrollment, which was independently adjudi-
cated by the patient-treating nephrologist. All patients 
were in sinus rhythm on ECG with no evidence of isch-
emia on exercise stress testing.
We excluded patients with preexisting cardiac dis-
ease, including coronary artery disease, heart failure, 
or arrhythmias, as well as patients with active malig-
nancy, disabling stroke, or concomitant medical co-
morbidity limiting life span to <12 months. Patients with 
greater than mild valvular disease or moderate mitral 
annular calcification and those with impaired LV ejec-
tion fraction (LVEF) were also excluded.
Study Protocol
Included participants received clinical evaluation (in-
cluding history for coexistent cardiac risk factors and 
CLINICAL PERSPECTIVE
What Is New?
• This study evaluated the relationship between 
resting left atrial function by strain analysis and 
exercise capacity in patients with chronic kidney 
disease.
• Left atrial reservoir strain was the strongest rest-
ing echocardiographic parameter associated 
with exercise capacity and had similar diagnos-
tic performance as exercise E/e’ in detection of 
reduced exercise capacity.
What Are the Clinical Implications?
• Left atrial reservoir strain may serve as a bio-
marker of functional capacity in chronic kidney 
disease populations and can be useful in pa-
tients who are unable to exercise because of 
limiting comorbidities or frailty.
• As exercise capacity is a known prognostic 
marker for adverse cardiovascular outcomes, 
identifying patients with chronic kidney disease 
with impaired left atrial reservoir strain may also 
improve cardiovascular risk stratification.
Nonstandard Abbreviations and Acronyms
LAScd left atrial conduit strain
LASct left atrial contractile strain
LASr left atrial reservoir strain
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medications), blood pressure assessment, and ECG 
was recorded at rest. All patients underwent a com-
prehensive resting transthoracic echocardiogram 
immediately followed by an exercise stress echocar-
diogram. Our study was approved by the Human 
Research and Ethics Committee of New South Wales 
(HREC/14/LPOOL/304). All participants provided writ-
ten informed consent.
Transthoracic Echocardiogram
Transthoracic echocardiogram was performed using 
commercial ultrasound systems (GE Healthcare, 
Horten, Norway) in accordance with recommenda-
tions of the American Society of Echocardiography.13 
Additional dedicated images optimizing the left ventri-
cle and left atrium were acquired at high frame rates 
(>70 frames/s). All images were stored digitally, and 
analysis was performed offline.
LV end-diastolic and end-systolic volumes were 
traced in the apical 4- and 2-chamber views. LVEF was 
calculated by Simpson’s biplane method. Normal LVEF 
was defined as ≥52% for men and ≥54% for women.14 
LV mass was calculated using the Devereux formula at 
end diastole and indexed to body surface area to derive 
the LV mass index. LV hypertrophy was defined as mass 
index of ≥95 g/m2 for women and ≥114 g/m2 for men.14
Diastolic function was evaluated from transmitral 
E and A velocities, E/A ratio, average of the sep-
tal and lateral annular e’ velocity and E/e’ ratio.15 
Diastolic grade was evaluated as per current guide-
lines.15 Biplane LA volume was evaluated from apical 
4- and 2-chamber views by the modified method of 
discs and indexed to body surface area to derive the 
indexed LA volume (LAVI).16 LA emptying volume was 
determined by the difference between LA maximum 
and LA minimum volume. LA ejection fraction (LAEF) 
was calculated by the LA emptying volume/LA max-
imum volume.16
Speckle-Tracking Echocardiography
Strain analysis was performed with customized com-
puter software (EchoPAC Version BT13, GE Healthcare).
The LV endocardium was traced at end systole in 
the 3 apical views; software analysis provided a region 
of interest,) which was adjusted when required to ac-
commodate the thickness of the LV myocardium. An 
18-segment LV model (6 segments in each apical view) 
was obtained; global longitudinal strain was measured 
as the average of 18 segments.17 We defined impaired 
LV global longitudinal strain as ≤−17%, based on previ-
ously published lower limit reference value.18
For LA strain, the LA endocardium was manu-
ally traced in end systole and software automatically 
tracked the myocardium throughout the cardiac cycle 
using R-to-R gating on electrocardiography.19 The 
region of interest was adjusted to the smallest LA wall 
thickness for tracking. The LA wall was divided into 6 
segments (basal, mid, and apical segments) in the api-
cal 4- and 2-chamber views.19 Figure 1 shows the LA 
strain curve throughout the cardiac cycle. In the reser-
voir phase, as the left atrium fills and stretches, there 
is positive atrial strain that reaches its peak in systole 
at the end of LA filling and before opening of the mitral 
valve, which is measured as LA reservoir strain (LASr). 
Following this, passive LA emptying ensues with open-
ing of the mitral valve, resulting in decreased atrial 
strain with negative deflection of the strain curve up to 
a plateau period, which is analogous to diastasis and 
is measured as LA conduit strain (LAScd). A second 
negative deflection in the strain curve is then observed 
corresponding to atrial systole, representing LA con-
tractile strain (LASct).17
LASr is measured at the end of the reservoir phase as 
the average of the peak systolic strain from 12 segments, 
LASct is measured as the peak positive strain following 
P wave (atrial contraction) and LAScd as the difference 
between peak reservoir and contractile strain.17,19 We 
defined impaired LASr as ≤23% based on a previously 
reported lower limit reference value for LASr.20
Exercise Echocardiography
Exercise stress testing was performed using stand-
ard treadmill protocols with 12-lead ECG monitoring. 
Patients were encouraged to exercise to maximal ef-
fort. Medications likely to suppress heart rate response 
with exercise were withheld for 24 hours before stress 
testing. In the event of resting hypertension, antihy-
pertensive therapy was commenced or up titrated. 
Exercise echocardiogram would be performed follow-
ing improvement in hypertension.
Post-exercise images were obtained according to 
standardized protocols for stress echocardiography 
from apical and parasternal images.21 Additionally, 
transmitral peak E velocity and septal and lateral anan-
ular e’ velocities were obtained; post-exercise E/e’ 
was calculated with an average of septal and lateral e’ 
measurements.22
The maximum predicted heart rate was calculated 
according to age [100%×(220-age)]17 with a maximal 
heart rate of ≥85% considered to be the target heart 
rate. The rate pressure product was calculated as the 
product of heart rate and systolic blood pressure at 
peak exercise. Exercise capacity was assessed as es-
timated metabolic equivalents (METs), calculated from 
the peak exercise intensity treadmill speed and grade.
Statistical Analysis
Statistical analyses were performed using IBM SPSS 
Statistics version 22.0 (SPSS, Inc., Chicago, Illinois). All 




 http://ahajournals.org by on Septem
ber 2, 2021
J Am Heart Assoc. 2021;10:e017840. DOI: 10.1161/JAHA.120.017840 4
Gan et al LA Strain Predicts Exercise Capacity in CKD
statistically significant. Data were presented as 
mean±SD for continuous variables and as number 
and percentage for categorical variables. To facilitate 
clinical interpretation, the summaries of baseline clini-
cal and echocardiographic data were presented over-
all and by tertile of METs. The association between 
tertiles of METs and ordered categorical variables 
were assessed by chi-squared trend tests. One-way 
ANOVA with Bonferroni correction or its nonparametric 
equivalent, the Kruskal-Wallis test, was used for con-
tinuous variables. Pearson or Spearman correlation 
coefficients (for normally distributed and non–normally 
distributed data, respectively) were used to quantify 
the strength of linear association between continuous 
variables.
General linear regression analysis was used to eval-
uate the relative contribution of the clinical and resting 
echocardiographic variables to exercise capacity. The 
variables that exhibited significant univariable associa-
tion with METs achieved were considered as candidate 
variables for inclusion in the multivariate models used 
to determine the independent predictors of METs. 
Partial r was the association between the variable 
and METs achieved. The standardized coefficient was 
the change in METs achieved associated with a 1 SD 
change in the variables.
Receiver operating characteristic curves and the 
area under the curve (AUC) was used to quantify the 
global performance of LASr and other echocardio-
graphic parameters of interest in classifying those 
with reduced exercise capacity. DeLong tests were 
used for pairwise comparisons of the AUC. Inter- and 
intraobserver variability for LA strain indices were eval-
uated by estimating intraclass correlation coefficients.
RESULTS
Patient Characteristics
The final cohort consisted of 218 (mean age, 
63.9±11.7  years; 64% men) prospectively recruited 
patients with stage 3 and 4 CKD (Figure  2). Nine 
patients were excluded—4 with atrial fibrillation on 
ECG, 2 attributable to impaired LVEF, and 3 with 
evidence of myocardial ischemia on exercise stress 
echocardiography.
The mean eGFR was 40.0±16.1 mL/min per 1.73 m2, 
and the mean creatinine was 170.3±94.2  µmol/L. 
Hypertensive nephrosclerosis (32%) accounted for the 
most common cause of CKD in the cohort. This was 
followed by diabetic nephropathy (30%) and primary 
and secondary glomerulonephropathies (17%).
Table 1 describes the clinical and echocardiographic 
parameters in the cohort. As per study protocol, all pa-
tients were in sinus rhythm with stable renal function for 
at least 3 months before enrollment and without prior 
cardiac disease or ischemia on stress testing. A high 
prevalence of vascular risk factors was present in the co-
hort (90% with hypertension, 45% with diabetes mellitus, 
and 73% with hypercholesterolemia). Anemia, defined as 
a hemoglobin level of <120 g/L for women and <130 g/L 
for men,23 was present in 24% of patients.
The mean resting systolic and diastolic blood 
pressure of the cohort was 132.4±17.4  mm  Hg and 
Figure 1. LA strain curve.
Left panel: Two-dimensional speckle tracking strain demonstrating phasic LA strain (LASr, LAScd, and 
LASct) from the apical 4 chamber view. Segmental strain from 6 segments as well as global LA strain 
(white dotted line) is shown. Right panel: Phasic LA function relative to the ECG. LA indicates left atrial; 
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76.7±11.4  mm  Hg, respectively. The average resting 
heart rate was 77.4±13.3 bpm.
Resting Echocardiography
All patients had normal LVEF. Thirty-four percent of the 
cohort had increased LV mass index, and 33% had an 
elevated resting E/e’ ratio of >14. The mean LV global 
longitudinal strain was −19.4±3.8%, and using the 
lower limit of normal reference value of ≤−17%,18 24% 
had impaired LV global longitudinal strain.
Of the atrial indices, the mean LAVI was 
31.3±8.8 mLs/m2 and 32% had LA enlargement with 
LAVI ≥34 mL/m2. The mean LASr, LAScd, and LASct 
were 24.1±7.6%, 16.4±6.5%, and 17.2±5.3%, respec-
tively. Based on the lower limit of reference value of 
≤23%,20 half of the cohort (50%) had impaired LASr.
Based on current recommendations of diastolic 
grading, 42% of patients had normal diastolic function, 
19% had indeterminate diastolic function, and 39% 
had impaired diastolic function.
Reduced Exercise Capacity
Table 1 summarizes the baseline clinical and echocar-
diographic data by tertile of METs achieved. Patients 
with the poorest exercise capacity (tertile 1: METs 
≤5.2) were more often women of older age with higher 
body mass index (BMI) and lower eGFR (P<0.01 for 
all). Higher rates of vascular risk factors (hypertension, 
diabetes mellitus, and hypercholesterolemia; P<0.01 
for all) were noted among these patients in addition to 
higher rates of anemia (P<0.01). No differences in blood 
pressures at rest or at peak exercise were appreciated.
Of the echocardiographic variables evaluated, 
higher rates of diastolic dysfunction (P<0.01) were ob-
served among patients with CKD with reduced exer-
cise capacity. These patients also had higher E velocity 
(P<0.01), lower average e’ velocity (P<0.01), higher 
resting E/e’ ratio (P<0.01), and higher exercise E/e’ 
ratio (P<0.01). There were no differences in pulmonary 
pressures.
With regard to atrial metrics, lower LASr, LAScd, 
and LASct (P<0.01 for all) were observed in patients 
with CKD with reduced exercise capacity. Though 
there was a trend toward larger LAVI (P=0.05), this 
failed to reach statistical significance. No difference in 
LA ejection fraction (P=0.56) was seen.
Independent Associations of Exercise 
Capacity
METs achieved with exercise had a moderate in-
verse correlation with age (r=−0.49; P<0.01) and BMI 
(r=−0.30, P<0.01) and a modest positive correlation 
to eGFR (r=0.33; P<0.01). As expected, men had 
greater exercise capacity than women (P<0.01) and 
the magnitude of this difference increased only mar-
ginally with age (Figure  3). Of the echocardiographic 
variables, LASr (r=0.70; P<0.01) showed the strong-
est correlation to METs achieved followed by exercise 
E/e’ (r=−0.65; P<0.01). Other echocardiographic cor-
relates include resting E/e’ (r=−0.41; P<0.01), LAScd 
(r=−0.38; P<0.01), LASct (r=−0.35; P<0.01), diastolic 
grade (r=−0.27; P≤0.01), and LAVI (r=−0.18; P<0.01), all 
of which demonstrated only modest correlations.
To determine the independent associations of exer-
cise capacity, we performed linear regression models 
based on candidate clinical and echocardiographic 
variables that showed a significant univariable as-
sociation with METs achieved. The clinical variables 
included age, sex, hypertension, diabetes mellitus, 
eGFR, anemia, and BMI. Although hypercholesterol-
emia was associated with reduced exercise capacity, 
it was not included in multivariable models to prevent 
overfitting, in particular given its low association with 
Figure 2. Study protocol and patient characteristics.
A total of 218 patients with stable renal function without prior 
cardiac history included. Nine patients were excluded, 3 because 
of myocardial ischemia on stress testing, 2 with impaired LVEF, 
and 4 with AF. AF indicates atrial fibrillation; CKD, chronic 
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METs achieved and the lack of biological plausibility on 
its impact on exercise capacity. As our aim was to de-
termine the optimal resting echocardiographic param-
eter that predicted exercise capacity, the candidate 
echocardiographic variables we included were LASr, 
LAScd, LASct, resting E/e’, LAVI, and diastolic grade.
The multivariate models are shown in Table 2; separate 
models were fitted for LASr, LAScd, and LASct. To avoid 
Table 1. Clinical, Echocardiographic, and Exercise Characteristics Based on Tertiles of METs Achieved











Age, y, mean (SD)y 63.9 (11.7) 69.4 (9.7)*,† 65.3 (10.3)* 56.8 (11.4) <0.01
Female sex, n (%) 76 (36) 39 (53)*,† 24 (33) 16 (22) <0.01
BMI, kg/m2, mean (SD) 29.7 (6.1) 32.2 (7.0)*,† 29.2 (5.6) 27.5 (4.5) <0.01
eGFR, mL/min per 1.73 m2, mean (SD) 40.0 (16.1) 33.9 (13.8)*,† 41.6 (13.7) 44.8 (18.4) <0.01
Hypertension, n (%) 196 (90) 71 (96)* 66 (92) 59 (82) 0.02
Diabetes mellitus, n (%) 99 (45) 42 (57)* 32 (44) 25 (35) 0.03
Hypercholesterolemia, n (%) 158 (73) 63 (85)*,† 48 (67) 47 (65) 0.01
Anemia, n (%) 53 (24) 27 (37%)* 15 (21) 11 (15) <0.01
SBP, mm Hg, median (IQR) 131.0 (127.0–140.0) 133.0 (125.0–145.0) 130.0 (120.0–140.5) 130.0 (120.0–143.0) 0.39
DBP, mm Hg, median (IQR) 79.0 (70.0–85.0) 75.0 (68.0–82.0) 72.0 (69.5–81.0) 80.0 (71.5–90.0) 0.06
HR, beats/min, median (IQR) 76.0 (67.0–86.0) 77.0 (67.0–86.0) 78.0 (65.5–88.0) 75.0 (69.0–85.0) 0.93
Baseline echocardiography
LVMI, g/m2, mean (SD) 97.6 (28.7) 100.6 (30.5) 98.7 (28.7) 93.4 (26.8) 0.30
LVEDV, mL, mean (SD) 69.1 (26.3) 70.7 (28.7) 65.7 (27.1) 70.9 (22.9) 0.41
LVESV, mL, mean (SD) 28.1 (13.9) 28.0 (14.8) 27.4 (15.1) 29.1 (11.7) 0.74
LVEF, %, mean (SD) 59.9 (6.2) 60.7 (6.5) 59.6 (6.1) 59.4 (6.0) 0.41
LVGLS, %, mean (SD) 19.4 (3.8) 19.3 (4.0) 19.2 (4.2) 19.7 (3.3) 0.69
E, mean (SD), m/sec 0.7 (0.2) 0.8 (0.2)* 0.7 (0.2) 0.7 (0.2) <0.01
E/A, mean (SD) 1.0 (0.5) 1.0 (0.8) 0.9 (0.4) 1.0 (0.5) 0.80
E’, mean (SD), cm/s 0.06 (0.02) 0.06 (0.02)* 0.06 (0.02)* 0.07 (0.02) <0.01
E/e’, mean (SD) 13.6 (5.3) 15.5 (5.9)* 14.3 (5.3)* 10.9 (3.3) <0.01
Diastolic grade
* Normal, n (%) 91 (42) 22 (30)* 25(35)* 44(61) <0.01
* Indeterminate, n (%) 41 (19) 13 (18) 16(22) 12(17) 0.66
* Diastolic dysfunction, n (%) 86 (39) 39 (53)* 31(43)* 16(22) <0.01
LAVI, mL/m2, mean (SD) 31.3 (8.8) 32.7 (9.5)* 30.8 (8.1) 29.3 (8.6) 0.05
LAEF, %, mean (SD) 62.7 (9.9) 62.0 (11.3) 62.5 (9.9) 63.7 (8.3) 0.56
LASr, %, mean (SD) 24.1 (7.6) 19.1 (5.3)*,† 23.1 (6.2)* 30.1 (6.6) <0.01
LAScd, %, mean (SD) 16.4 (6.5) 13.4 (5.2)*,† 16.3 (5.7)* 19.3 (7.1) <0.01
LAScr, %, mean (SD) 17.2 (5.3) 15.3 (5.1)* 16.9 (5.1)* 19.4 (5.0) <0.01
PASP, mm Hg, mean (SD) 16.9 (11.4) 18.0 (13.3) 14.8 (10.6) 16.9 (11.4) 0.22
Exercise parameters
Peak SBP, mm Hg, median (IQR) 166.0 (150.0-180.0) 160.0 (145.0-180.0) 165.0 (150.0-170.0) 170.0 (160.0-180.0) 0.06
Peak DBP, mm Hg, median (IQR) 80.0 (70.0-95.0) 80.0 (70.0-98.0) 80.0 (70.0-95.0) 80.0 (70.0-94.0) 0.55
Peak HR, beats/min, median (IQR) 139.0 (121.0-151.0) 127.0 (110.0-146.0)*,† 141.0 (123.0-152.0)* 148.0 (136.5-160.0) <0.01
Exercise duration, min, mean (SD) 7.1 (4.1) 4.9 (2.7)*,† 6.6 (2.6)* 10.0 (4.9) <0.01
Exercise E/e’, mean (SD) 14.2 (5.6) 17.7 (6.5)*,† 14.4 (4.3)* 10.4 (2.6) <0.01
BMI indicates body mass index; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; HR, heart rate; IQR, interquartile range; LAEF, 
left atrial ejection fraction; LAScd, left atrial conduit strain; LASct, left atrial contractile strain; LASr, left atrial strain; LAVI, left atrial volume indexed; LVEDV, left 
ventricular end diastolic volume; LVEF, left ventricular ejection fraction; LVESV, left ventricular end systolic volume; LVGLS, left ventricular global longitudinal 
strain; LVMI, left ventricular mass indexed; PASP, pulmonary artery systolic pressure; and SBP, systolic blood pressure.
*P<0.05 to tertile 3.
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overfitting, we used nested models: model 1, comprising 
clinically significant variables; model 2a, 2b, 2c, compris-
ing echocardiographic variables for LASr, LAScd, and 
LASct; model 3a, 3b, 3c, comprising combined indepen-
dent clinical and echocardiographic variables of model 1 
and model 2. A final model was performed combining all 
the independent variables from the nested model (model 
4). Normal probability plots of the residuals in each model 
showed a good fit with no departure from normality, and 
there was no collinearity between variables in the models 
assessed with all variation inflation figures <2 on collinear-
ity diagnostics. Correlation analysis was also performed 
for age and eGFR, which showed no significant correla-
tion between both variables.
Age, sex, BMI, and eGFR were independent clin-
ical predictors of METs achieved in the multivariable 
model. Of the echocardiographic parameters, LASr, 
LAScd, LASct, and resting E/e’ were associated with 
exercise capacity in the echocardiographic models, 
but only LASr, LASct, and resting E/e’ remained in-
dependent predictors of METs achieved in the com-
bined clinical and echocardiographic models (models 
3a, 3b, 3c). In the final model (model 4), LASr was 
the only independent echocardiographic predictor of 
METs achieved.
To evaluate the performance of the independent 
echocardiographic variables, we compared the AUC of 
receiver operating characteristic curves of LASr, LASct, 
and resting E/e’ to exercise E/e’ (Figure 4). Overall, LASr 
(AUC, 0.83; 95% CI, 0.78–0.88; P<0.01) was the stron-
gest resting echocardiographic predictor of reduced 
exercise capacity, with a similar diagnostic performance 
to exercise E/e’ (AUC, 0.79; AUC area difference, 0.05; 
95% CI, −0.02 to 0.12; P=0.20 on DeLong test). Exercise 
E/e’ remained superior to LASct and resting E/e’ in pre-
dicting reduced exercise capacity.
Relationship of LASr to METs Achieved 
With Exercise
To assess the clinical value of LASr, we constructed a 
linear regression model combining LASr and the inde-
pendent clinical predictors of exercise capacity (age, 
sex, eGFR, and BMI). Using unstandardized coeffi-
cients derived from the model, we performed overlay 
scatter plots of METs achieved with exercise and pre-
dicted METs derived from the model. A strong positive 
linear relationship between the predicted METs of the 
model to METs achieved with exercise was observed. 
In patients with CKD, the addition of LASr to age, sex, 
BMI, and eGFR provided a robust prediction of METs 
achieved with exercise.
Inter- and Intraobserver Variability
LA strain was analyzed by 2 different individuals and 
by the same individual on a different day to evaluate 
inter- and intra-observer variability. There was good 
overall agreement and reproducibility of LA strain 
indices. The inter- and intraobserver interclass cor-
relation for LASr was 0.97 (0.92–0.99) and 0.98 
(0.95–0.99), for LAScd was 0.96 (0.93–0.98) and 
0.96 (0.93–0.99), and for LASct was 0.98 (0.94–0.99) 
and 0.97 (0.93–0.99).
DISCUSSION
In this study, we demonstrated for the first time the 
association between resting LA function by strain as-
sessment, and exercise capacity in patients with CKD. 
In patients with stage 3 and stage 4 CKD, LASr was 
the strongest resting echocardiographic parameter as-
sociated with reduced exercise capacity, with similar 
diagnostic performance as exercise E/e’ in detection of 
reduced exercise capacity. A multivariable model com-
bining LASr and clinical correlates of exercise (older 
age, female sex, higher BMI, and reduced eGFR) pro-
vided a robust prediction of METs achieved with exer-
cise in patients with CKD.
Exercise Capacity in CKD
Reduction in physical function and exercise capac-
ity in patients with CKD is common and evident even 
in the early stages of renal disease.24 The underlying 
pathophysiological processes are multifactorial and 
Figure 3. METs achieved during exercise with increasing age 
in men and women.
Men had greater exercise capacity than women and the magnitude 
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Figure 4. ROC curves of exercise E/e’, LASr, LASct, and resting E/e’ with DeLong tests.
LASr was the strongest independent predictor of reduced exercise capacity amongst resting echocardiographic 
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broadly relate to both irregularities in oxygen delivery 
(eg, vascular dysfunction) and extraction mechanisms 
(eg, skeletal muscle). With advancing renal disease, 
altered vascular tone attributable to endothelial dys-
function and increased vascular stiffness impair the 
capacity of peripheral vessels to dilate in response to 
increased shear stress during exercise.25 Moreover, 
oxidative stress and proinflammatory states, both as-
sociated with CKD and heart failure with preserved 
ejection fraction, contribute to muscle wasting and 
have been found to correlate with physical fitness.26,27 
Microvascular endothelial inflammation is also asso-
ciated with endothelial dysfunction and microvascu-
lar rarefaction, disease processes integral to tissue 
oxygenation.28
LA Function and Exercise Capacity
There is mounting evidence that LA dysfunction is a 
contributor to cardiorespiratory symptoms and exer-
cise capacity.29,30 Among unselected individuals re-
ferred for exercise stress echocardiogram, Kusunose et 
al31 showed a strong association between reduced LA 
strain and impaired exercise capacity. Impaired LASr and 
LASct has also been associated with abnormal exercise 
dynamics and elevated pulmonary pressures among pa-
tients with heart failure and preserved ejection fraction.32
As the interplay between atrial phasic function 
and ventricular mechanics is essential for modula-
tion of cardiovascular performance, these findings 
are unsurprising.16 Impaired LA function can impose 
greater hemodynamic stress on the pulmonary vas-
culature and has been shown to be a robust cor-
relate of elevated pulmonary vascular resistance and 
peak volume of oxygen, above and beyond tradi-
tional markers of diastolic function including the E/e’ 
ratio and LA volume.33 Additionally, chronic pulmo-
nary venous congestion in the setting of abnormal 
LA mechanics results in altered pulmonary artery 
compliance, which hinders oxygen delivery and gas 
exchange.34
Of interest, although diastolic dysfunction has 
been linked with impaired exercise capacity in unse-
lected patients 35 and patients with CKD,6 our study 
demonstrated that impaired LASr in the absence of 
diastolic dysfunction was also strongly associated 
with impaired exercise capacity. This would suggest 
that in addition to the hemodynamic changes con-
sequent to diastolic dysfunction, pathophysiological 
mechanisms specific to CKD likely contribute to LA 
remodeling and dysfunction, that is, development of 
an atrial myopathy.
Mechanism for LA Dysfunction in CKD
Studies have shown that CKD is an independent fac-
tor affecting LA function36,37 and that alterations in LA 
strain occur before changes in LA volumes.10 In pa-
tients with heart failure with preserved ejection frac-
tion, Unger et al9 demonstrated incremental reductions 
in LASr parallel to reductions in eGFR that was inde-
pendent of clinical and other echocardiographic co-
variates, implying that pathophysiological mechanisms 
specific to CKD are also additive and worsen with pro-
gression of renal impairment.
Inflammation, consequent to uremia and local wall 
stress, have been proposed as a contributing mech-
anism, with a strong relationship between LA dilata-
tion and high-sensitivity C-reactive protein reported 
in patients with stage 3 to 5 CKD.38 This is similar to 
observations in patients with atrial fibrillation in whom 
increased inflammatory markers, including C-reactive 
protein and interleukin-6, have been linked to atrial 
size.39 Additionally, neurohormonal changes, oxida-
tive stress attributable to anti-oxidative imbalance as 
well as excessive sympathetic nerve excitation also 
play a role.40 Enhanced angiotensin II activity by re-
nin-angiotensin-aldosterone system upregulation, 
together with other downstream mediators such as 
transforming growth factor-beta 1, results in pro-
gressive myocardial fibrosis,41 which manifests ear-
lier and is more evident in the atrium, a thin-walled 
structure. Furthermore, changes in autonomic activ-
ity may trigger profibrotic signaling pathways, further 
driving atrial dysfunction.42
Clinical Relevance
Though utility of LA strain is largely confined to the 
research arena at present, a growing body of litera-
ture supports its use particularly in the evaluation of 
specific populations with diastolic dysfunction, where 
it has been shown to be an independent predictor of 
all-cause mortality.43
As exercise capacity is a known prognostic marker 
for adverse cardiovascular outcomes,1,44 the potential 
application of our findings cannot be understated. In 
patients who are unable to exercise because of limiting 
comorbidities or frailty, resting LASr can be used as 
an alternative to exercise E/e’. Identifying patients with 
CKD with impaired LASr may also improve cardiovas-
cular risk stratification and intensification of risk factor 
management in this patient group at risk of developing 
adverse cardiovascular events.
STRENGTHS AND LIMITATIONS
Our study had stringent eligibility criteria and included 
only patients with stable stage 3 and stage 4 CKD with 
low cardiovascular risk without myocardial ischemia 
on stress testing recruited across 2 large tertiary 
centers. Though our sample size was modest, more 
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Furthermore, although strain measurement has an in-
trinsic limitation of variability, we had good level of re-
producibility of measurements.
We used calculated METs as a measure of exer-
cise tolerance rather than oxygen consumption, which 
although a more robust measure, is seldom used in 
routine clinical practice and was beyond the scope of 
this study. Further, B-type natriuretic peptide levels were 
not available in this group as patients were low risk, as-
ymptomatic, and without cardiovascular disease. Finally, 
although LA strain is increasingly used, it is currently 
measured using a software package developed for the 
evaluation of LV strain, which has intrinsic limitations.
CONCLUSIONS
In patients with stable stage 3 and 4 CKD without prior 
cardiac disease, LASr had the strongest association 
with reduced exercise capacity, superior to other rest-
ing echocardiographic parameters and with similar 
diagnostic performance as exercise E/e’. The use of 
LASr may serve as a biomarker of functional capacity 
in this population and could be used as a therapeutic 
target to monitor effects of treatments.
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